Moreover, the secretion of TGF-β by tumor cells directly impedes the immune activity of CTLs by inducing the upregulation of miR-23a and simultaneous downregulation of B-lymphocyte-induced maturation protein 1(Blimp-1) (59). The gene discussed is PRDM1; the disease is neoplasm.